About RootPath Genomics
RootPath Genomics is a company based in Cambridge (United States) founded in 2017.. RootPath Genomics has raised $68 million across 3 funding rounds from investors including CDH, Sky9 Capital and Matrix. The company has 16 employees as of December 31, 2022. RootPath Genomics operates in a competitive market with competitors including Celgene, Denali Therapeutics, eGenesis, MiRagen and Poseida Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 16 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rootpath Genomics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$68 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series B
Sep 07, 2021
-
Investors
CDH
& 7 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of RootPath Genomics
RootPath Genomics has successfully raised a total of $68M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $50.0M
-
First Round
First Round
(30 Aug 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series B - RootPath Genomics | Valuation | CDH , Sky9 Capital | |
| Jan, 2020 | Amount | Series A - RootPath Genomics | Valuation | Yuanhe Holdings | |
| Aug, 2018 | Amount | Seed - RootPath Genomics | Valuation | Sequoia Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RootPath Genomics
RootPath Genomics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include CDH, Sky9 Capital and Matrix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and private debt firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Tech investments are made stage-agnostically in China and the US.
|
Founded Year | Domain | Location | |
|
Early-stage ventures are funded by the investment firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RootPath Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RootPath Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rootpath Genomics Comparisons
Competitors of RootPath Genomics
RootPath Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Denali Therapeutics, eGenesis, MiRagen and Poseida Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rootpath Genomics
Frequently Asked Questions about RootPath Genomics
When was RootPath Genomics founded?
RootPath Genomics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is RootPath Genomics located?
RootPath Genomics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is RootPath Genomics a funded company?
RootPath Genomics is a funded company, having raised a total of $68M across 3 funding rounds to date. The company's 1st funding round was a Seed of $7M, raised on Aug 30, 2018.
How many employees does RootPath Genomics have?
As of Dec 31, 2022, the latest employee count at RootPath Genomics is 16.
What does RootPath Genomics do?
RootPath Genomics was founded in 2017 in Cambridge, United States, within the biotechnology sector. An immunotherapy platform centered on T cell therapy is operated to deliver personalized cancer treatments. Immune cells are analyzed and engineered using genetic engineering and computational biology techniques. The approach enables the creation of immune-based cell therapies tailored to individual patients, with operations focused on advancing oncology solutions.
Who are the top competitors of RootPath Genomics?
RootPath Genomics's top competitors include Juno Therapeutics, eGenesis and Poseida Therapeutics.
Who are RootPath Genomics's investors?
RootPath Genomics has 8 investors. Key investors include CDH, Sky9 Capital, Matrix, Yuanhe Holdings, and Sequoia Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.